Trypanosoma rangeli
Trypanosoma rangeli is a species of Trypanosoma.
It is considered nonpathogenic in humans.[1][2]
It has been proposed for use in the prevention of Chagas disease.[3][4]
References
- ^ de Moraes MH, Guarneri AA, Girardi FP, et al. (2008). "Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera". Parasit Vectors 1 (1): 20. doi:10.1186/1756-3305-1-20. PMC 2475519. PMID 18611261. http://www.parasitesandvectors.com/content/1/1/20.
- ^ "Definition: Trypanosoma rangeli from Online Medical Dictionary". http://cancerweb.ncl.ac.uk/cgi-bin/omd?Trypanosoma+rangeli.
- ^ Basso B, Castro I, Introini V, Gil P, Truyens C, Moretti E (May 2007). "Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi". Vaccine 25 (19): 3855–8. doi:10.1016/j.vaccine.2007.01.114. PMID 17349724. http://linkinghub.elsevier.com/retrieve/pii/S0264-410X(07)00173-9.
- ^ Basso B, Moretti E, Fretes R (June 2008). "Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection". Mem. Inst. Oswaldo Cruz 103 (4): 370–4. doi:10.1590/S0074-02762008000400010. PMID 18660992. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000400010&lng=en&nrm=iso&tlng=en.